Revalesio Corp

SEC filing

Pharmaceuticals · Tacoma, WA

Form D on EDGAR

Amount raised$38.9Msold at filing

Total offering$40.3M$1.4M still open

Investors in the raise31count reported to the SEC

FiledDec 16, 2025first sale May 25, 2022

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

JAMES NORDSTROMDirector

ERIC RUSSELLDirector

GREG ARCHAMBEAUExecutive Officer

CHRIS FIBIGERDirector

BERT VAN DEN BERGHDirector

JANE TAYLORDirector

MATT IRELANDDirector

Executive officers, directors and promoters as listed on the Form D.